1,412 results on '"Uemura, Hiroji"'
Search Results
152. Additional file 2 of Shared decision making, physicians’ explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients
153. Additional file 5 of Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
154. Additional file 6 of Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
155. Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer
156. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy
157. Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients
158. Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
159. Complete ureteral stenosis after ureteroscopic lithotripsy successfully managed using a simultaneous retrograde and antegrade flexible ureteroscopic approach
160. A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel
161. Impact of depression on overactive bladder
162. Use of metallic and polymeric ureteral stents in malignant ureteral obstruction
163. The development and validation of a prognostic nomogram and nomogram application software among men treated with abiraterone acetate and/or enzalutamide for metastatic castration-resistant prostate cancer
164. Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer
165. A low psoas muscle volume is associated with a poor prognosis in penile cancer
166. A novel prognostic model for Japanese patients with newly diagnosed bone‐metastatic hormone‐naïve prostate cancer
167. Re: Geriatric 8 screening of frailty in patients with prostate cancer
168. Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐223
169. Prognosis and safety of radium‐223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration‐resistant prostate cancer: Real‐world data of Japanese patients
170. Efficacy and Safety Exposure–Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer
171. THE EFFICACY OF ONCO-TESTICULAR SPERM EXTRACTION (ONCO-TESE): A SINGLE-CENTER ANALYSIS
172. Impact of smoking habit on overactive bladder symptoms and incontinence in women
173. Angiotensin Receptor Blockers and Risk of Prostate Cancer Among United States Veterans
174. Ureteroscopy assisted retrograde nephrostomy: a new technique for percutaneous nephrolithotomy (PCNL)
175. Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer
176. Preoperative stenting for ureteroscopic lithotripsy for a large renal stone
177. Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study.
178. Which is the best method to estimate the actual ureteral length in patients undergoing ureteral stent placement?
179. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis
180. High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy
181. Coexpression of aPKCλ/ι and IL-6 in prostate cancer tissue correlates with biochemical recurrence
182. Regulation of Androgen Receptor Expression Through Angiotensin II Type 1 Receptor in Prostate Cancer Cells
183. Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer
184. Clinical outcome of surgical management for symptomatic metastatic spinal cord compression form prostate cancer.
185. Age-Specific Crisis Awareness Survey for Coronavirus Disease 2019 (COVID-19): How Much Do You Think You Should Pay for Hypothetical Prophylactic Vaccine and Therapeutic Drug for COVID-19?
186. Comparative effectiveness of surgery and radiotherapy for survival of patients with clinically localized prostate cancer: A population‑based coarsened exact matching retrospective cohort study
187. A retrospective study on the possible systematic inflammatory response markers to predict the prognosis of patients with bladder cancer undergoing radial cystectomy
188. A lower psoas muscle index predicts a poorer prognosis in metastatic hormone‐naïve prostate cancer
189. Skin Rash Following Administration of Apalutamide in Japanese Patients with Advanced Prostate Cancer: An Integrated Analysis of the Phase 3 SPARTAN and TITAN Studies and a Phase 1 Open-Label Study
190. Skin Metastasis of Renal Cell Carcinoma
191. Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study
192. A Case of Retroperitoneal Ganglioneuroma Accidentally Discovered by Laparoscopic Right Adrenalectomy
193. Genetic disorders and male infertility
194. Does screening for prostate cancer improve cancer‐specific mortality in Asian men? Real‐world data in Yokosuka City 15 years after introducing PSA‐based population screening
195. Final survival results from SPARTAN, a phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC).
196. Renal Squamous Cell Carcinoma with Staghorn Calculus
197. Re: Current treatment strategies for advanced prostate cancer
198. Pediatric bilateral ureteral stone successfully removed using single‐use flexible ureteroscopy with a holmium: YAG laser
199. Who is a bone-predominant patient to maximize clinical benefits of radium-223 dichloride?
200. Personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel: A randomized, double-blind, placebo-controlled, phase III trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.